The abnormal cardiac structural and functional changes associated with diabetic cardiomyopathy are promoted by chronic hyperglycemia, hyperinsulinemia, and resistance to the metabolic actions of insulin in the heart[272], with cardiovascular event risk quantifiably correlated to the level of glycemic control[273]. The gene discussed is INS; the disease is diabetic cardiomyopathy.